| Up
2005P-0423:
Immediately Add a Black Box Warning Regarding the Risks of Drug-induced
Blindness for the Three Phosphodiesterase 5 Inhibitors that are
Prescribed for the Treatment of Erectile Dysfuntion
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
|
| CP1
|
| 10/20/2005
|
| 10/20/2005
|
| Consumer Group
|
| Public Citzen's Health
Research Group
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| Elizabeth Barbehenn, Ph.D. et.
al.
|
|
|
|
|
| ACK1
|
| 10/20/2005
|
| 10/20/2005
|
| Federal Government
|
| HFA-305 to Public
Citzen's Health Research Group
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| Lyle D. Jaffe
| |
|
|
|
| EC1
|
| 10/27/2005
|
| 10/22/2005
|
| Health Care Association
|
| IRB
|
|
|
|
|
|
|
| htm
|
|
|
|
|
|
|
| Signature:
|
| Wolberg, Rev Richard
|
|
|
|
|
| EC2
|
| 10/27/2005
|
| 10/26/2005
|
| Individual Consumer
|
| Mr. Peter Iano
|
|
|
|
|
|
|
| htm
|
|
|
|
|
|
|
| EC3
|
| 12/19/2005
|
| 12/14/2005
|
| Individual Consumer
|
| Ms. Irene Ferraiuolo
|
|
|
|
|
|
|
| htm
|
|
|
|
|
|
|
| LET1
|
| 04/19/2006
|
| 04/19/2006
|
| Federal Government
|
| HFD-005 to Public
Citizen's Health Research Group
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
|
| Signature:
|
| Jane A. Axelrad
|
|
|
|
|
| C1
|
| 05/22/2006
|
| 05/17/2006
|
| Individual Consumer
|
| D. Lowe
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C2
|
| 06/07/2006
|
| 06/06/2006
|
| Drug Industry
|
| Pfizer, Inc.
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| Cathryn M. Clary, MD
|
|
|
|
|
| LET2
|
| 06/07/2006
|
| 06/06/2006
|
| Drug Industry
|
| Pfizer, Inc.
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| Richard Siegel, M.D.
| |
Top | Up
Page last updated
July 26, 2006
kk
Dockets Home Page | Dockets
Contacts and Location | Operating
Status | Item
Code Definitions | Federal
Register
FDA Home Page | Search
FDA Site | FDA A-Z Index
| Contact FDA
FDA/Dockets Management |
